OpenAI’s $500 B “Stargate” Circles Britain—But the UK Grid Could Pull the Plug
SoftBank’s mega–data‑center dream meets Keir Starmer’s red‑tape bonfire, a 15‑year grid queue, and jealous rivals in Paris and Berlin.
Stay up-to-date on the latest breakthroughs and trends shaping the world of artificial intelligence. Discover the most recent developments, industry updates, and critical discussions around AI ethics and governance from trusted sources.
SoftBank’s mega–data‑center dream meets Keir Starmer’s red‑tape bonfire, a 15‑year grid queue, and jealous rivals in Paris and Berlin.
Sequential Monte Carlo turns 7‑B models into syntax snipers, jolting a coding‑assistant market already chasing a $10 B Cursor valuation.
OpenAI’s o1-pro model upgrade for ChatGPT Pro users brings sharper reasoning and real-world task skills, but its steep cost raises questions about accessibility.
Alibaba and Meta challenge OpenAI with rival AI models as lawsuits and regulations loom, signaling a fierce battle for AI supremacy in 2025.
AI’s coding at insane speeds—10x faster than humans—fueling chaos and awe in software. Here’s the raw scoop on this tech revolution.
An AI breakthrough decodes ancient scripts—Sumerian, Egyptian, Greek—with insane speed, unearthing lost worlds. Here’s how this wild tech is shaking history.
Read how a cutting-edge AI model detects cancer with 99.26% accuracy, paving the way for early diagnosis and better treatment options in healthcare.
Learn how Nvidia’s latest AI superchips boost speed and memory, transforming cloud computing and self‑driving vehicles with real-world impact.
Anthropic has published the system prompts for its Claude generative AI models, including Claude 3 Haiku, Claude 3 Opus, and Claude 3.5 Sonnet. This move has set a new standard for transparency in AI development, while Anthropic’s competitors continue to keep their development a closely guarded secret.
Researchers from Iraq and Australia have created an AI-powered tongue scanner that uses modern technology to detect diseases like diabetes, cancer, and COVID-19.